21. NICE guidance on nintedanib for previously treated locally advanced, metastatic, or locally recurrent non-small-cell lung cancer. Issue 9 (September 2015) Authors: Hall, Caroline J; Hay, Nicola; George, Elisabeth; Adler, Amanda I Journal: Lancet oncology Issue: Volume 16:Issue 9(2015:Sep.) Page Start: 1019 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. NICE guidance on nintedanib for treating idiopathic pulmonary fibrosis. Issue 3 (March 2016) Authors: Laurenson, Sophie; Sidhu, Raisa; Goodall, Melinda; Adler, Amanda I Journal: Lancet Issue: Volume 4:Issue 3(2016) Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. NICE guidance on nivolumab plus ipilimumab for untreated, unresectable malignant pleural mesothelioma. Issue 10 (October 2022) Authors: Adler, Amanda I; Slayen, Samuel; Stegenga, Heather; Guo, Yelan; Diaz, Richard; Welton, Nicky J; Westwood, Nigel; Doull, Iolo; Crawley, Charles Journal: Lancet Issue: Volume 10:Issue 10(2022) Page Start: e92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. NICE guidance on nivolumab with ipilimumab for untreated advanced renal cell carcinoma. Issue 7 (July 2019) Authors: Adler, Amanda I; Brooke, Adam; Elsada, Ahmed; Landells, Linda Journal: Lancet oncology Issue: Volume 20:Issue 7(2019) Page Start: 904 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. NICE guidance on pomalidomide for relapsed and refractory multiple myeloma previously treated with lenalidomide and bortezomib. Issue 5 (May 2015) Authors: Burke, Martyn J; George, Elisabeth; Adler, Amanda I Journal: Lancet oncology Issue: Volume 16:Issue 5(2015:May) Page Start: 492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. NICE guidance on sorafenib for treating advanced hepatocellular carcinoma. (November 2017) Authors: Adler, Amanda I; Sutcliffe, Frances Journal: Lancet gastroenterology and hepatology Issue: Volume 2:Number 11(2017) Page Start: 781 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. NICE guidance on sotagliflozin for type 1 diabetes. Issue 4 (April 2020) Authors: Adler, Amanda I; Cronshaw, Jessica; Prescott, Carl; Patel, Sanjeev; Donegan, Eleanor; Hayre, Jasdeep Journal: Lancet Issue: Volume 8:Issue 4(2020) Page Start: 274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Nintedanib for treating progressive fibrosing interstitial lung diseases. Issue 12 (December 2021) Authors: Adler, Amanda I; Guo, Yelan; Thiam, Aminata; Elliott, Nicole; Patel, Sanjeev Journal: Lancet Issue: Volume 9:Issue 12(2021) Page Start: e116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Ocrelizumab for primary progressive multiple sclerosis. Issue 9 (September 2019) Authors: Adler, Amanda I; Knight, Helen Journal: Lancet neurology Issue: Volume 18:Issue 9(2019) Page Start: 816 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗